Current through Register Vol. 46, No. 43, October 23, 2024
Section 130.16 - Laboratory Sampling Firm Approval(a) No person may conduct sampling and transportation of cannabis product or medical cannabis and any other intermediates or forms for purposes of testing such cannabis product or medical cannabis by a cannabis laboratory unless they have been granted approval as a laboratory sampling firm; except where the registered organization or adult-use licensee, are authorized by the Office to submit samples.(b) Prior to approval, a laboratory sampling firm shall submit a description of the sampling and transportation process describing how cannabis product or medical cannabis and any other intermediates or forms will be sampled and transported in the field or on premises, or a copy of the standard operating procedure addressing sampling and transportation.(c) Approval of a laboratory sampling firm and its employees shall be conducted in a manner and format determined by the Office.(d) Approval shall be effective for a period not to exceed two (2) years and shall expire on March 31.(e) Approval of a laboratory sampling firm is not transferable or assignable, including, without limitation, to another laboratory sampling firm.(f) A cannabis laboratory may receive conditional approval as a laboratory sampling firm with a written waiver from the Office. The Office may provide a waiver if the Office determines that a cannabis laboratory has met the conditions specified in sections 130.16 - 130.21 of this Part.(g) A cannabis laboratory sampling firm and its true parties of interest shall have no interest in a registered organization, adult-use cultivator, processor, distributor, retail dispensary, cooperative, microbusiness, delivery, nursery, on-site consumption, registered organization with dispensing or ROD and a registered organization non-dispensing or ROND as defined in Part 118 of this Title, or any other license pursuant to the Cannabis Law.N.Y. Comp. Codes R. & Regs. Tit. 9 § 130.16
Adopted New York State Register March 22, 2023/Volume XLV, Issue 12, eff. 3/22/2023